Product Information

LEVSIN-SL 0.125 MG TABLET SL is a brand product labeled by Viatris Specialty LLC, priced at $2.7044 per EA under NDC 68220011310. Its NADAC has been published 88 times since Sep 18, 2024.

The High Outlier badge above means this manufacturer's average price in the hyoscyamine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LEVSIN-SL 0.125 MG TABLET SL

hyoscyamine sulfate
$2.7044per EA
High Outlier

Strength

.125 mg/1

NDC

68220011310

Classification

Brand

Dosage Form

TABLET, ORALLY DISINTEGRATING

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

HYOSCYAMINE SULFATE

Approval Type

Unapproved

On Market Since

12/1/2008

Price Statistics

The NADAC for LEVSIN-SL 0.125 MG TABLET SL has been published 88 times since Sep 18, 2024, and over the history we have for it it has risen 5.6%. The table below summarizes its recorded NADAC range and movement.

Current price$2.7044 per EA
All-time high$2.7142 (Jul 15, 2026)
All-time low$2.5253 (Oct 23, 2024)
52-week high$2.7142
52-week low$2.6515
Median price$2.6515
Average price$2.6411
Largest weekly change+5.0% (Jan 15, 2025)
Weeks tracked88
Tracking sinceSep 18, 2024

Price History

1W

0.0%

1M

0.0%

3M

-0.4%

6M

+2.0%

1Y

+2.0%

3Y

N/A

5Y

N/A

All

+5.6%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of LEVSIN-SL 0.125 MG TABLET SL?

The current National Average Drug Acquisition Cost (NADAC) for LEVSIN-SL 0.125 MG TABLET SL, manufactured by Viatris Specialty LLC, is $2.7044 per EA (NDC 68220011310), effective Aug 19, 2026.

How has the price of LEVSIN-SL 0.125 MG TABLET SL changed over time?

Over the history we have for it, the NADAC for LEVSIN-SL 0.125 MG TABLET SL has risen 5.6%. It has been tracked across 88 weekly CMS publications since Sep 18, 2024.

What are the highest and lowest recorded NADAC prices for LEVSIN-SL 0.125 MG TABLET SL?

Since Sep 18, 2024, the NADAC for LEVSIN-SL 0.125 MG TABLET SL has ranged from a low of $2.5253 (Oct 23, 2024) to a high of $2.7142 (Jul 15, 2026), with a median of $2.6515 per EA.

Are there cheaper alternatives to LEVSIN-SL 0.125 MG TABLET SL?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYOSCYAMINE SULF 0.125 MG TAB, is $0.1515 per EA — about 94% below LEVSIN-SL 0.125 MG TABLET SL.

Who manufactures LEVSIN-SL 0.125 MG TABLET SL?

LEVSIN-SL 0.125 MG TABLET SL (NDC 68220011310) is labeled by Viatris Specialty LLC, and CMS classifies it as a brand product.